Scott A. Greenwell, President of PharMerica at BrightSpring Health Services, Inc., filed a Form 4 on September 16, 2026, reporting stock option exercises and a same-day open-market sale of common stock on September 14, 2026, under a Rule 10b5-1 plan.
Key Highlights
- Option exercise: Greenwell exercised 11,973 stock options at an exercise price of $22.27 per share on September 14, 2026, acquiring 11,973 shares of common stock.
- Open-market sale: Greenwell disposed of 15,099 shares of common stock at $57.91 per share on the same date.
- Remaining direct ownership: Following the transactions, Greenwell directly holds 31,246 shares of common stock.
- Remaining options: Greenwell holds 23,947 stock options (right to buy) with an exercise price of $22.27 and an expiration date of June 20, 2035.
- Rule 10b5-1 plan: The filing indicates the transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- Vesting schedule: According to the filing, the options vest in three equal annual installments commencing on June 20, 2026.
Greenwell's Option Exercise and Share Disposal at BrightSpring Health Services
According to the filing, Scott A. Greenwell, who serves as President of PharMerica, an officer role at BrightSpring Health Services, Inc. (NASDAQ:BTSG), conducted two transactions in the company's common stock on September 14, 2026. The filing was signed by Jennifer Phipps as Attorney-in-Fact and submitted on September 16, 2026.
The first transaction was coded "M," reflecting the exercise of 11,973 stock options at a conversion price of $22.27 per share. These options carry an expiration date of June 20, 2035, and the filing states they vest in three equal annual installments beginning June 20, 2026. Following the exercise, Greenwell's direct beneficial ownership rose to 46,345 shares before the second transaction. The second transaction, coded "S," was the disposal of 15,099 shares at a price of $57.91 per share, reducing Greenwell's direct common stock holdings to 31,246 shares.
On the derivative securities side, Greenwell's remaining directly held stock options number 23,947 following the exercise of 11,973 options reported in this filing. The filing notes the transactions were executed under a written plan consistent with Rule 10b5-1(c), as indicated by the checked box on the form.
What Was Disclosed
The Form 4 reported an option exercise of 11,973 shares at $22.27 and a sale of 15,099 shares at $57.91 by BrightSpring Health Services officer Scott A. Greenwell on September 14, 2026, leaving him with 31,246 shares of common stock held directly.




Please wait processing your request...